Olga Stenina, Ph.D. | Research | Publications

Publications

Raman P, et al. Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem  2007;282:5704-14.

Stenina OI, Topol EJ, Plow EF. Thrombospondins, their polymorphisms, and cardiovascular disease. Arterioscler Thromb Vasc Biol  2007;27:1886-94.

Elzbieta Pluskota, Olga I. Stenina, Irene Krukovets, Dorota Szpak, Edward F. Plow (2005). Differential effect of A387 and P387 Thrombospondin-4 variants on Human Neutrophils. Blood, 106:3970.

Olga I. Stenina, Valentin Ustinov, Irene Krukovets, Tina Marinic, Eric J. Topol and Edward F. Plow (2005). Polymorphisms A387P in Thrombospondin-4 and N700S in Thrombospondin-1 Perturb Calcium Binding Sites. FASEB Journal, 19: 1893-1895.

Olga I. Stenina and Edward F. Plow (2005). Cancer, Thrombosis and the MET Oncogene: Old Mystery, New Insights (News and Views). Nature Medicine, 11: 4-5.

Olga I. Stenina (2005). Regulation of vascular genes by glucose (review). Current Pharmaceutical Design, 11 (18) : 2367-2381.

Olga I. Stenina, Tatiana V. Byzova, Josephine C. Adams, Jeanette J. McCarthy, Eric J. Topol and Edward F. Plow (2004). Coronary Artery Disease and the Thrombospondin Single Nucleotide Polymorphisms (review). International Journal of Biochemistry and Cell Biology, special issue “Modulatory Adhesion Molecules in Tissue Homeostasis” (ed. J. Adams), 36: 1013-1030.

Olga I. Stenina, Shailesh Desai, Irene Krukovets, Kelly Kight, Damir Janigro, Eric J. Topol and Edward F. Plow (2003). Expression of thrombospondin-4 by endothelial cells and differential effect of thrombospondin variants on function of endothelial cells. Circulation, 108:1514-1519.

Olga I. Stenina, Irene Krukovets, Kai Wang, Farhad Farudi, Zhongmin Zhou, Marc Penn, Eric J. Topol and Edward F. Plow (2003). The increased expression of thrombospondin-1 in the vessel wall of diabetic Zucker rat. Circulation, 107:3209-3215.

Olga I. Stenina (2003). Regulation of gene expression in vascular cells by coagulation proteins (review). Current Drug Targets, 4: 143-158.

Topol EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, Newby LK, Freedman M, Metivier J, Cannata R, O'Donnell CJ, Kottke-Marchant K, Murugesan G, Plow EF, Stenina O, Daley GQ. (2001). Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation, 104: 2641 -2644.

Stenina O., Pudota B. N., McNally B. A., Hommema E. L., Berkner K. L. (2001). Tethered processivity of the vitamin K-dependent carboxylase: factor IX is efficiently modified in a mechanism which distinguishes gla's from glu's and which accounts for comprehensive carboxylation in vivo. Biochemistry, 40:10301-10309.

Olga I. Stenina, Kristin M. Shaneyfelt and Paul E. DiCorleto (2001). Thrombin induces the release of the Y-box protein dpbB from mRNA: a new mode of transcription factor activation. Proc. Natl. Acad. Sci., 98(13): 7277-7282.

Olga I. Stenina, Earl J. Poptic, and Paul E. DiCorleto (2000). Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. J Clin Invest, 106(4): 579-587.

Babaev V.R., Bobryshev Yu. V., Stenina O.I., Tararak E.M. (1990). Phenotypic variants of the smooth muscle cells in an atheromatous plaque of the human aorta. Archive of Pathology (russ), 52(5): 16-21.

Babaev V.R., Bobryshev Yu. V., Stenina O.I., Tararak E.M., Gabbiani G. (1990). Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am.J.Pathol., 136(5):1031-42.

Stenina O.I., Zacharova O.S., Bobryshev Yu. V., Repin V.S. (1989). Endothelial injuries: the role in the vessel pathology (review). In: Sums of the science and technics. Human and animal physiology (russ), 38:89-133, VINITI, Moscow.

Stenina O.I., Baldenkov G.N., Tkachuk V.A., Repin V.S.(1989). Nitroglycerol prevents receptor-mediated massive deendothelialization in the perfused rabbit aorta. J. Mol.Cell Cardiol., 21:S20.

Stenina O.I., Baldenkov G.N., Tkachuk V.A., Repin V.S.(1989). Ca2+-channel blockers prevent receptor-mediated endothelial damage in the perfused rabbit aorta. J. Mol.Cell Cardiol., 21:S20.

Stenina O.I., Voyno-Yassenetskaya T.A., Bobryshev Yu. V., Repin V.S., Aiken J.W. (1988). Massive deendothelialization in rabbit and human aorta mediated by simultaneous application of the stable analog of thromboxane A2 U44,069 and beta-adrenoreceptor agonist isoproterenol. Cardiovascular World Report, 1(1): 60-67.

Stenina O.I., Voyno-Yassenetskaya T.A., Menshikov G.B., Repin V.S. (1988). An agonist of beta-adrenergic receptors isoproterenol enhances angiotensin II-dependent injury of rabbit aortic endothelium. Bull. Exp. Biol. Med. (russ), 10: 433-436.

Kondakov I.K., Voyno-Yassenetskaya T.A., Stenina O.I., Repin V.S. (1988). The comparative ultrastructural characteristic of endothelial injuries produced by catecholamines using scanning and transmission electron microscopy. Archive of Pathology (russ).

Voyno-Yassenetskaya T.A., Stenina O.I., Repin V.S., Skuratovskaya L.N., Guliaeva R.V., Kryzhanovsky G.N. (1988). Receptor-dependent injury to the perfused rabbit and human aorta. Bulleten of Academy of Medical Science of USSR (russ), 2:89-93.

Dolgov V.V., Preobrazhensky S.N., Stenina O.I., Bondarenko M.F., Repin V.S. (1982). The quantitative analysis of LDL interaction with perfused rabbit aorta. Bull. Exp. Biol. Med. (russ), 10:122-124.